Literature DB >> 15118545

Cryptococcus neoformans Infection in Patients With Cirrhosis, Including Liver Transplant Candidates.

Nina Singh1, Shahid Husain, Michael de Vera, Timothy Gayowski, Thomas V Cacciarelli.   

Abstract

We reviewed the cases of patients with cirrhosis, including liver transplant candidates, at our institution in the last 3 years (n = 5) and those individually described in the literature (n = 28), to assess unique characteristics and outcome of cryptococcosis in these patients. Sixty-four percent (21/33) of the patients had no other recognized immunosuppression. Peritonitis (in 45%, 15/33 of the patients) with modest pleocytosis in the ascitic fluid, was the most common presenting feature. Median time to detection of Cryptococcus in the ascitic fluid cultures was 6 days. Overall mortality rate was 81% (26/32); death was deemed attributable to cryptococcosis in 24/26 patients who died. Evaluation of culture-negative neutrocytic ascites in febrile cirrhotic patients warrants consideration of cryptococcal peritonitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118545     DOI: 10.1097/01.md.0000126760.45299.69

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  31 in total

1.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

2.  Challenges in dealing with a cirrhotic patient.

Authors:  Diana Spinelli; Sarah Damanti; Francesca Minonzio; Cinzia Hu; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2012-03-15       Impact factor: 3.397

3.  Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis.

Authors:  S Y Hwang; S J Yu; J-H Lee; J S Kim; J W Yoon; Y J Kim; J-H Yoon; E-C Kim; H-S Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-02       Impact factor: 3.267

4.  Use of a suspension array for rapid identification of the varieties and genotypes of the Cryptococcus neoformans species complex.

Authors:  Mara R Diaz; Jack W Fell
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Cryptococcus neoformans infection in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected patients at an inner-city tertiary care hospital in the Bronx.

Authors:  Hyun Ah Yoon; Uriel Felsen; Tao Wang; Liise-Anne Pirofski
Journal:  Med Mycol       Date:  2020-06-01       Impact factor: 4.076

6.  Cirrhosis, gastrointestinal bleed, and cryptococcal peritonitis.

Authors:  Amy E Barnett; Karen B Brust
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-02-11

Review 7.  Host immunity to Cryptococcus neoformans.

Authors:  Soma Rohatgi; Liise-Anne Pirofski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

8.  Cryptococcosis in patients living with hepatitis C and B viruses.

Authors:  Fernanda Sá Spies; Markus Berger de Oliveira; Monique Siebra Krug; Cecilia Bittencourt Severo; Luiz Carlos Severo; Marilene Henning Vainstein
Journal:  Mycopathologia       Date:  2014-12-21       Impact factor: 2.574

9.  Cryptococcal infections in non-HIV-infected patients.

Authors:  Peter G Pappas
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

10.  Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease.

Authors:  J W Baddley; J R Perfect; R A Oster; R A Larsen; G A Pankey; H Henderson; D W Haas; C A Kauffman; R Patel; A K Zaas; P G Pappas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.